EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lipid control in a cohort of patients with cardiorenal disease (LIPID-REN): a subanalysis of the CARDIOREN registry

Ramón Garrido-González, Almudena Castro, Rafael de la Espriella iD, Jara Gayán Ordás, Isabel Zegrí-Reiriz, Pau Llácer iD, Aleix Fort, Adriana Rodríguez Chavarri, Ana Méndez, Zorba Blázquez-Bermejo, Pedro Caravaca Pérez, Jorge Rubio Gracia und 7 weitere

Clinical Kidney Journal · 02.11.2026 · 19 (11)

DOI: 10.1093/ckj/sfag369 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Kidney Journal, online erschienen am 15.10.2026. Verfasst von Ramón Garrido-González und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda (IDIPHISA), Madrid, Spain. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AstraZeneca Spain.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Advanced chronic kidney disease (CKD) confers a very high cardiovascular disease (CVD) risk, requiring comprehensive risk factor assessment. However, real-world data on current practices in patients with cardiorenal disease remain limited. We aimed to evaluate the control of cardiovascular risk factors, with a focus on lipid management, in a contemporary cardiorenal cohort.

Methods

This cross-sectional analysis was conducted within the CARDIOREN Registry, which enrolled patients with chronic heart failure from 13 tertiary hospitals in Spain (2021–2022). Of 1107 patients, 885 with complete data on low-density lipoprotein cholesterol (LDL-C), albuminuria, and atherosclerotic CVD (ASCVD) were eligible. The present analysis was restricted to the patients who met the definition of advanced CKD, defined as estimated glomerular filtration rate (eGFR) <30 ml/min/1.73 m² or eGFR 30–45 ml/min/1.73 m² with albuminuria >30 mg/g. ASCVD was defined as prior ischemic heart disease, stroke, or peripheral arterial disease. The proportion of patients with LDL-C <55 mg/dl was assessed. Multivariable logistic regression models, including a parsimonious primary model and sensitivity analyses, were used to identify factors associated with lower LDL-C levels.

Results

Advanced CKD was present in 221 patients (25%); median age was 79 years, 58.8% were male, and 52.9% had ASCVD. Median LDL-C was 73 mg/dl, and only 22.6% achieved an LDL-C <55 mg/dl. Achievement of LDL-C <55 mg/dl was significantly lower in patients without ASCVD compared with those with ASCVD (13.4% vs. 30.7%; P = .002). In multivariable analysis, ASCVD was independently associated with a higher likelihood of achieving LDL-C <55 mg/dl, whereas female sex was independently associated with a lower likelihood of achieving this level.

Conclusions

In patients with advanced CKD, lipid control was below cardiology guideline recommendations for patients at very high CVD risk, particularly among those without ASCVD and in women.

Schlagwörter

Stichwörter der Autor:innen

atherosclerosiscardiorenal diseasechronic renal failuredyslipidemiaheart failure

Autor:innen und Institutionen

  • Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda (IDIPHISA), Madrid, Spain.
  • Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
  • Department of Cardiology, Hospital Universitario La Paz, Madrid, Spain.
  • Department of Cardiology, Hospital Clínico Universitario de Valencia (INCLIVA), Valencia, Spain.
  • Department of Cardiology, Hospital Universitario Arnau de Vilanova, Institut de Recerca Biomèdica de Lleida (IRBLleida), Lleida, Spain.
  • Department of Cardiology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

ORCID-Profile: Rafael de la Espriella, Pau Llácer, Jose Luis Górriz, Maria Jose Soler, Julio Núñez, Marta Cobo Marcos

Förderung

  • AstraZeneca Spain

Zitieren

APA

Garrido-González, R., Castro, A., de la Espriella, R., Gayán Ordás, J., Zegrí-Reiriz, I., Llácer, P., Fort, A., Rodríguez Chavarri, A., Méndez, A., Blázquez-Bermejo, Z., Caravaca Pérez, P., Rubio Gracia, J., Recio-Mayoral, A., García Pinilla, J. M., Collado Macián, C., Górriz, J. L., Soler, M. J., Núñez, J., & Cobo Marcos, M. (2026). Lipid control in a cohort of patients with cardiorenal disease (LIPID-REN): a subanalysis of the CARDIOREN registry. Clinical Kidney Journal, 19(11). https://doi.org/10.1093/ckj/sfag369

Vancouver

Garrido-González R, Castro A, de la Espriella R, Gayán Ordás J, Zegrí-Reiriz I, Llácer P, et al. Lipid control in a cohort of patients with cardiorenal disease (LIPID-REN): a subanalysis of the CARDIOREN registry. Clinical Kidney Journal. 2026;19(11). doi:10.1093/ckj/sfag369

BibTeX
@article{GarridoGonzlez2026,
  author = {Garrido-González, Ramón and Castro, Almudena and de la Espriella, Rafael and Gayán Ordás, Jara and Zegrí-Reiriz, Isabel and Llácer, Pau and Fort, Aleix and Rodríguez Chavarri, Adriana and Méndez, Ana and Blázquez-Bermejo, Zorba and Caravaca Pérez, Pedro and Rubio Gracia, Jorge and Recio-Mayoral, Alejandro and García Pinilla, Jose Manuel and Collado Macián, Carlos and Górriz, Jose Luis and Soler, Maria Jose and Núñez, Julio and Cobo Marcos, Marta},
  title = {Lipid control in a cohort of patients with cardiorenal disease (LIPID-REN): a subanalysis of the CARDIOREN registry},
  journal = {Clinical Kidney Journal},
  year = {2026},
  volume = {19},
  number = {11},
  doi = {10.1093/ckj/sfag369}
}
Kostenlos starten →